EAM
EFG Asset Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,959
| Closed | -$1.65M | – | 182 |
|
|
2024
Q4 | $1.65M | Sell |
8,959
-2,845
| -24% | -$525K | 0.23% | 168 |
|
|
2024
Q3 | $2.32M | Sell |
11,804
-5,131
| -30% | -$1.01M | 0.39% | 111 |
|
|
2024
Q2 | $3.5M | Buy |
16,935
+1,571
| +10% | +$324K | 0.61% | 44 |
|
|
2024
Q1 | $4.16M | Buy |
15,364
+1,934
| +14% | +$524K | 0.72% | 37 |
|
|
2023
Q4 | $3.17M | Sell |
13,430
-598
| -4% | -$141K | 0.6% | 62 |
|
|
2023
Q3 | $2.75M | Buy |
14,028
+770
| +6% | +$151K | 0.65% | 55 |
|
|
2023
Q2 | $2.79M | Buy |
13,258
+2,167
| +20% | +$456K | 0.6% | 55 |
|
|
2023
Q1 | $2.24M | Buy |
+11,091
| New | +$2.24M | 0.49% | 67 |
|